Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 78
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis

    Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...

    Predicting and improving persistence during exposure-based therapy for OCD

    The efficacy of exposure-based therapies for obsessive compulsive disorder (OCD) is among the most well...

    Mosquitoes as Flying Syringes: The Solution to Rapid Zika Monitoring

    Yes, mosquitoes are flying syringes! They sample human blood as a normal part of their life cycle. We can...

    Backer Badge Funded